Source:http://linkedlifedata.com/resource/pubmed/id/21173509
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-2-4
|
pubmed:abstractText |
Fine-needle aspiration cytology (FNAC) is the primary means to distinguish benign thyroid nodules from malignant ones. About 20% of FNAC yields indeterminate results leading to unnecessary or delayed surgery. Many studies of tissue samples, the majority of which are retrospective advocate testing for RET rearrangements as a diagnostic adjunctive tool in thyroid nodules with indeterminate cytological findings. Because of the uncertain prevalence of RET rearrangements, its utility as a tumor marker is still controversial. The goal of this study was to establish the prevalence and the utility of testing for RET rearrangements in FNAC suspicious of cancer in a clinical setting. In this prospective study, we analysed a large series of thyroid aspirates by RT-PCR only and Southern blot on RT-PCR products for type 1 and 3 RET rearrangements. Results were compared with clinical findings, cytological diagnosis and final histopathology. By the higher sensitive Southern-blot on RT-PCR method, RET rearrangements were present in 36% of papillary thyroid carcinomas (RET/PTC-1, 12%; RET/PTC-3, 20%; both, 4%) and of 13.3% of benign nodules. By means of RT-PCR only, RET rearrangements were disclosed only in 14.3% of PTC and in 3.6% of benign nodules. No significant correlation was found between RET rearrangements and clinicopathological features of patients. These results indicate that molecular testing of thyroid nodules for RET/PTC must take into account of its high prevalence in benign nodules, inducing false positive diagnoses when the highly sensitive assay Southern-blot on RT-PCR is used. Its searching by means of RT-PCR only, has a specificity superior of conventional cytology and can be used to refine inconclusive FNAC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1348-4540
|
pubmed:author |
pubmed-author:CampanileElisabettaE,
pubmed-author:FenziGianfrancoG,
pubmed-author:FilogranaAA,
pubmed-author:GuerraAnnaA,
pubmed-author:LimonePaolo PieroPP,
pubmed-author:MarottaVincenzoV,
pubmed-author:MorettiMaria IlariaMI,
pubmed-author:MottaManuelaM,
pubmed-author:RossiGuidoG,
pubmed-author:SapioMaria RosariaMR,
pubmed-author:VitaleMarioM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-8
|
pubmed:dateRevised |
2011-6-16
|
pubmed:meshHeading |
pubmed-meshheading:21173509-Aged,
pubmed-meshheading:21173509-Biopsy, Fine-Needle,
pubmed-meshheading:21173509-Carcinoma, Papillary,
pubmed-meshheading:21173509-False Negative Reactions,
pubmed-meshheading:21173509-False Positive Reactions,
pubmed-meshheading:21173509-Female,
pubmed-meshheading:21173509-Gene Rearrangement,
pubmed-meshheading:21173509-Humans,
pubmed-meshheading:21173509-Male,
pubmed-meshheading:21173509-Middle Aged,
pubmed-meshheading:21173509-Proto-Oncogene Proteins c-ret,
pubmed-meshheading:21173509-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21173509-Sensitivity and Specificity,
pubmed-meshheading:21173509-Thyroid Neoplasms,
pubmed-meshheading:21173509-Thyroid Nodule
|
pubmed:year |
2011
|
pubmed:articleTitle |
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.
|
pubmed:affiliation |
Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università Federico II, Via S. Pansini 5, Naples, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|